These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3021301)

  • 21. [Pharmacologic and therapeutic perspectives on calcium inhibitors].
    Godfraind T
    Bull Mem Acad R Med Belg; 1982; 137(12):737-53. PubMed ID: 6309312
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of calcium channel blockers on the electromechanical activity of the frog myocardium during rhythmic stimulation and at rest].
    Gendvilene VI; Machianskene RA; Narushiavichius EV
    Dokl Akad Nauk SSSR; 1985; 281(2):444-7. PubMed ID: 3996207
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in the contractile function and energy metabolism of the isolated heart in chronic adriamycin damage to the myocardium].
    Kapel'ko VI; Saks VA; Popovich MI; Golikov MA; Veksler VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):46-52. PubMed ID: 3606833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinically significant drug-drug and drug-food interactions associated with calcium channel blockers].
    Imaura M; Ohno Y; Nakajima K; Suzuki H
    Clin Calcium; 2005 Oct; 15(10):1709-16. PubMed ID: 16199918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity.
    Adachi K; Fujiura Y; Mayumi F; Nozuhara A; Sugiu Y; Sakanashi T; Hidaka T; Toshima H
    Biochem Biophys Res Commun; 1993 Sep; 195(2):945-51. PubMed ID: 8373427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
    Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of the inhibition produced by adriamycin against specific enzymes in the rat heart].
    Fabregat I; Satrústegui J; Machado A
    Rev Esp Oncol; 1982; 29(4):633-40. PubMed ID: 6100465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
    Bast A; Kaiserová H; den Hartog GJ; Haenen GR; van der Vijgh WJ
    Cell Biol Toxicol; 2007 Jan; 23(1):39-47. PubMed ID: 17063376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic involvement in adriamycin cardiotoxicity.
    Seraydarian MW; Artaza L; Yang JJ
    Adv Myocardiol; 1980; 2():213-23. PubMed ID: 7423039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of adriamycin cardiotoxicity by enoximone.
    Bossa R; Bissoli M; Chiericozzi M; Cozzi R; Galatulas I; Salvatore G
    Anticancer Res; 1996; 16(1):141-3. PubMed ID: 8615599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimiental pretreatment with calcium-mobilizing drugs for the prevention of cardiomyopathy induced by anthracycline antibiotics].
    Villani F; Piccinini F; Favilli L; Chiari M
    G Ital Chemioter; 1979; 26(1-2):263-8. PubMed ID: 554818
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological properties and use of calcium channel blockers].
    Kostowski W; Obersztyn M
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1701-5. PubMed ID: 6395120
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute adriamycin cardiotoxicity in rats.
    Porta EA; Joun NS; Matsumura L; Nakasone B; Sablan H
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):125-37. PubMed ID: 6622826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of calcium-entry blockade on left ventricular systolic and diastolic function.
    Walsh RA
    Circulation; 1987 Jun; 75(6 Pt 2):V43-55. PubMed ID: 3552316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological changes in organs of mice induced by the combination of adriamycin and pustulan.
    Fiszer-Maliszewska L; Mordarski M; Madej JA; Kotz J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):365-72. PubMed ID: 6651486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
    Berthiaume JM; Wallace KB
    Cardiovasc Toxicol; 2007; 7(3):178-91. PubMed ID: 17901561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
    Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
    Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats.
    Hamza A; Amin A; Daoud S
    Cell Biol Toxicol; 2008 Jan; 24(1):63-73. PubMed ID: 17520333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute adriamycin cardiotoxicity: morphologic alterations in isolated perfused rabbit heart.
    Taylor AL; Bulkley BH
    Lab Invest; 1982 Nov; 47(5):459-64. PubMed ID: 7132289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.